ARTICLE | Financial News
Galmed files for IPO
February 8, 2014 1:14 AM UTC
Lipid and liver disease company Galmed Pharmaceuticals Ltd. (Tel Aviv, Israel) filed to raise up to $34.5 million in an IPO on NASDAQ underwritten by Maxim. Next half, Galmed plans to start a Phase II...